University of Texas/MD Anderson Cancer Center MD Anderson PSC is a clinical research site located in Houston, Texas, United States 77030-4009.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Texas/MD Anderson Cancer Center MD Anderson PSC has participated in 3 clinical trials.
Therapeutic areas: Unspecified Adult Solid Tumor, Protocol Specific, Solid Tumor, Advanced/Metastatic Solid Tumors or Lymphomas.
Sponsors: Pfizer, Chinook Therapeutics, Inc. (formerly Aduro), Array Biopharma, now a wholly owned subsidiary of Pfizer.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Texas/MD Anderson Cancer Center MD Anderson PSC has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Texas/MD Anderson Cancer Center MD Anderson PSC has 3 clinical trials on record. Their work covers Unspecified Adult Solid Tumor, Protocol Specific, Solid Tumor, Advanced/Metastatic Solid Tumors or Lymphomas.
University of Texas/MD Anderson Cancer Center MD Anderson PSC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.